Viewing Study NCT01844869

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-02-27 @ 10:38 AM
Study NCT ID: NCT01844869
Status: COMPLETED
Last Update Posted: 2015-01-30
First Post: 2013-04-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancies View
None Solid Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None omacetaxine View
None omacetaxine mepesuccinate View
None pharmacokinetics View
None hematologic malignancies View
None advanced solid tumors View